Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Dyspnea is a prominent symptom in patients with long COVID due to its high prevalence and significant clinical impact. However, the influence of commonly used medications in critically ill patients on long-term dyspnea remains unclear. This study aimed to identify risk factors and assess the impacts associated with moderate to severe dyspnea in COV...
Alternative Titles
Full title
Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0278a2407b394b8fbf787e93f8978333
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0278a2407b394b8fbf787e93f8978333
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-025-91010-2
